Package 0228-3156-03

Brand: buprenorphine

Generic: buprenorphine
NDC Package

Package Facts

Identity

Package NDC 0228-3156-03
Digits Only 0228315603
Product NDC 0228-3156
Product ID 0228-3156_eb9e7c72-45fb-4455-a405-027cf06caac6
Description

30 TABLET in 1 BOTTLE (0228-3156-03)

Marketing

Marketing Status
Marketed Since 2015-04-10
Brand buprenorphine
Generic buprenorphine
Sample Package No

Linked Drug Pages (1)

Buprenorphine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "eb9e7c72-45fb-4455-a405-027cf06caac6", "openfda": {"unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["03819118-86f6-4329-adaf-4599e7b71f46"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0228-3156-03)", "package_ndc": "0228-3156-03", "marketing_start_date": "20150410"}], "brand_name": "Buprenorphine", "product_id": "0228-3156_eb9e7c72-45fb-4455-a405-027cf06caac6", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "0228-3156", "dea_schedule": "CIII", "generic_name": "Buprenorphine", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA090819", "marketing_category": "ANDA", "marketing_start_date": "20150219", "listing_expiration_date": "20271231"}